Correlation Between Equillium and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Equillium and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Equillium and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Rigel Pharmaceuticals.
Diversification Opportunities for Equillium and Rigel Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Equillium and Rigel is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Equillium i.e., Equillium and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Equillium and Rigel Pharmaceuticals
Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Rigel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Equillium is 1.82 times less risky than Rigel Pharmaceuticals. The stock trades about -0.09 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest 1,363 in Rigel Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 1,398 from holding Rigel Pharmaceuticals or generate 102.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Equillium |
| Rigel Pharmaceuticals |
Equillium and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Rigel Pharmaceuticals
The main advantage of trading using opposite Equillium and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges |